￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the target of neratinib?

2026-02-01 22:25:32

Check Details
CTL019 plus ibrutinib is feasible and effective in the treatment of relapsed/refractory MCL

2026-02-01 22:25:32

Check Details
Is ibrutinib/ibrutinib on the market?

2026-02-01 22:25:32

Check Details
How many pills are in a box of ibrutinib/ibrutinib?

2026-02-01 22:25:32

Check Details
Ibrutinib/ibrutinib medical insurance reimbursement time

2026-02-01 22:25:32

Check Details
What are the reactions after taking ibrutinib/ibrutinib?

2026-02-01 22:25:32

Check Details
Resistance management of ibrutinib/ibrutinib

2026-02-01 22:25:32

Check Details
Is ibrutinib/ibrutinib approved for marketing?

2026-02-01 22:25:32

Check Details
How many tablets does a box of ibrutinib/ibrutinib contain?

2026-02-01 22:25:32

Check Details
How long is the medical insurance reimbursement period for ibrutinib/ibrutinib?

2026-02-01 22:25:32

Check Details
What are the possible physical reactions after taking ibrutinib/ibrutinib?

2026-02-01 22:25:32

Check Details
What should I do if I develop drug resistance after taking ibrutinib/ibrutinib?

2026-02-01 22:25:32

Check Details
Category
相关知识